SignatureFD’s Oric Pharmaceuticals ORIC Stock Holding History

SignatureFD’s Portfolio ORIC Stock Details ORIC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$899	Hold	83	–	–	﹤0.01%	3280
2026 Q1	$1.05K	Hold	83	–	–	﹤0.01%	3200
2025 Q4	$679	Hold	83	–	–	﹤0.01%	3178
2025 Q3	$996	Hold	83	–	–	﹤0.01%	3090
2025 Q2	$842	Sell	83 -153	-65%	-$1.03K	﹤0.01%	3047
2025 Q1	$1.32K	Hold	236	–	–	﹤0.01%	2985
2024 Q4	$1.91K	Sell	236 -39	-14%	-$358	﹤0.01%	2888
2024 Q3	$2.82K	Buy	275 +39	+17%	+$386	﹤0.01%	2733
2024 Q2	$1.67K	Sell	236 -38	-14%	-$340	﹤0.01%	2802
2024 Q1	$3.77K	Hold	274	–	–	﹤0.01%	2624
2023 Q4	$2.52K	Buy	+274	New	+$1.98K	﹤0.01%	2706
2022 Q2	–	Sell	-22	Closed	–	–	3285
2022 Q1	$0	Sell	22 -14	-39%	-$126	﹤0.01%	3272
2021 Q4	$1K	Sell	36 -44	-55%	-$686	﹤0.01%	2966
2021 Q3	$2K	Buy	+80	New	+$1.62K	﹤0.01%	2687

Other funds holding ORIC

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

SignatureFD's ORIC Position: Q2 2026 in Review

SignatureFD held its Oric Pharmaceuticals (ORIC) position steady in Q2 2026 at 83 shares worth $899. The position accounts for ﹤0.01% of the portfolio, ranked #3280.

SignatureFD first reported a position in ORIC in Q3 2021 and has held it in 14 quarters since. The position peaked at $3.77K in Q1 2024. 180 funds tracked by Wall St. Rank hold ORIC as of Q2 2026.

SignatureFD held 83 shares of Oric Pharmaceuticals worth $899 as of Q2 2026.
SignatureFD left its Oric Pharmaceuticals share count unchanged in Q2 2026.
Oric Pharmaceuticals made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3280 holding.
SignatureFD first reported a position in Oric Pharmaceuticals in Q3 2021 and has held it in 14 quarters since.
SignatureFD's Oric Pharmaceuticals position peaked at $3.77K in Q1 2024.
180 funds tracked by Wall St. Rank held Oric Pharmaceuticals as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.